Author Reply: Decision-Making Management of Women with a High Risk of Developing Breast and Ovarian Cancer

Por Heemskerk-Gerritsen, Bernadette, Brekelmans, Cecile, Seynaeve, Caroline
Publicado em 2008

Severe akathisia as a side effect of metoclopramide

Por Van Gool, Arthur R., Doorduijn, Jeanette K., Seynaeve, Caroline
Publicado em 2010

Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major Toxicity

Por van der Hul, René L., Seynaeve, Caroline, van Geel, Bert N., Verweij, Jaap
Publicado em 2003

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

Por Drooger, Jan C., Heemskerk-Gerritsen, Bernadette A. M., Smallenbroek, Nyrée, Epskamp, Cynthia, Seynaeve, Caroline M., Jager, Agnes
Publicado no Breast Cancer Res Treat (2016)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younge...

Por Drooger, Jan C., Akdeniz, Delal, Pignol, Jean-Philippe, Koppert, Linetta B., McCool, Danielle, Seynaeve, Caroline M., Hooning, Maartje J., Jager, Agnes
Publicado no Breast Cancer Res Treat (2015)

Most women recover from psychological distress after postoperative complications following implant or DIEP flap breast reconstruction: A prospective long-term follow-up study

Por Timman, Reinier, Gopie, Jessica P., Brinkman, J. Nick, Kleijne, Annelies, Seynaeve, Caroline, Menke-Pluymers, Marian B. E., ter Kuile, Moniek M., Tibben, Aad, Mureau, Marc A. M.
Publicado no PLoS One (2017)

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

Por van Verschuer, Victorien MT, Heemskerk-Gerritsen, Bernadette AM, van Deurzen, Carolien HM, Obdeijn, Inge-Marie, Tilanus-Linthorst, Madeleine MA, Verhoef, Cornelis, Schmidt, Marjanka K, Koppert, Linetta B, Hooning, Maartje J, Seynaeve, Caroline
Publicado em 2014

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

Por Tan, Murly BM, Bleiker, Eveline MA, Menke-Pluymers, Marian BE, Van Gool, Arthur R, van Dooren, Silvia, Van Geel, Bert N, Tilanus-Linthorst, Madeleine MA, Bartels, Karina CM, Klijn, Jan GM, Brekelmans, Cecile TM, Seynaeve, Caroline
Publicado em 2009

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting

Por de Bock, Geertruida H, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly MM, Blom, Jannet, van Asperen, Christi J, Cornelisse, Cees J, Klijn, Jan GM, Devilee, Peter, Tollenaar, Rob AEM, Brekelmans, Cecile TM, van Houwelingen, Johannes C
Publicado em 2008

MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk

Por Knappskog, Stian, Gansmo, Liv B., Romundstad, Pål, Bjørnslett, Merete, Trovik, Jone, Sommerfelt-Pettersen, Jan, Løkkevik, Erik, Tollenaar, Rob A. E. M., Seynaeve, Caroline, Devilee, Peter, Salvesen, Helga B., Dørum, Anne, Hveem, Kristian, Vatten, Lars, Lønning, Per E.
Publicado em 2012

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor()

Por Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M., Hamberg, Paul, Dirix, Luc Y., Brouwer, Anja, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Van, Ngoc M., Foekens, John A., Martens, John W.M., Sleijfer, Stefan
Publicado no Neoplasia (2016)

Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

Por Hollestelle, Antoinette, Pelletier, Cory, Hooning, Maartje, Crepin, Ellen, Schutte, Mieke, Look, Maxime, Collee, J. Margriet, Nieuwlaat, Anja, Dorssers, Lambert C. J., Seynaeve, Caroline, Aulchenko, Yurii S., Martens, John W. M., van den Ouweland, Ans M. W., Weidhaas, Joanne B.
Publicado em 2010

Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic

Por Heemskerk-Gerritsen, Bernadette A. M., Brekelmans, Cecile T. M., Menke-Pluymers, Marian B. E., van Geel, Albert N., Tilanus-Linthorst, Madeleine M. A., Bartels, Carina C. M., Tan, Murly, Meijers-Heijboer, Hanne E. J., Klijn, Jan G. M., Seynaeve, Caroline
Publicado em 2007

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

Por Huijts, Petra EA, Vreeswijk, Maaike PG, Kroeze-Jansema, Karin HG, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly MM, Wijers-Koster, Pauline M, Blom, Jannet C, Pooley, Karen A, Klijn, Jan GM, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Publicado em 2007

Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor–Positive Breast Cancer: A TEAM Study Analysis

Por van de Water, Willemien, Bastiaannet, Esther, Hille, Elysée T.M., Meershoek-Klein Kranenbarg, Elma M., Putter, Hein, Seynaeve, Caroline M., Paridaens, Robert, de Craen, Anton J.M., Westendorp, Rudi G.J., Liefers, Gerrit-Jan, van de Velde, Cornelis J.H.
Publicado em 2012

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

Por Kriege, Mieke, Jager, Agnes, Hollestelle, Antoinette, Berns, Els M. J. J., Blom, Jannet, Meijer-van Gelder, Marion E., Sieuwerts, Anieta M., van den Ouweland, Ans, Collée, J. Margriet, Kroep, Judith R., Martens, John W. M., Hooning, Maartje J., Seynaeve, Caroline
Publicado no J Cancer Res Clin Oncol (2015)

MUTYH gene variants and breast cancer in a Dutch case–control study

Por Out, Astrid A., Wasielewski, Marijke, Huijts, Petra E. A., van Minderhout, Ivonne J. H. M., Houwing-Duistermaat, Jeanine J., Tops, Carli M. J., Nielsen, Maartje, Seynaeve, Caroline, Wijnen, Juul T., Breuning, Martijn H., van Asperen, Christi J., Schutte, Mieke, Hes, Frederik J., Devilee, Peter
Publicado em 2012

Elderly Postmenopausal Patients With Breast Cancer Are at Increased Risk for Distant Recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis

Por van de Water, Willemien, Seynaeve, Caroline, Bastiaannet, Esther, Markopoulos, Christos, Jones, Steve E., Rea, Daniel, Hasenburg, Annette, Putter, Hein, Hille, Elysée T.M., Paridaens, Robert, de Craen, Anton J.M., Westendorp, Rudi G.J., van de Velde, Cornelis J.H., Liefers, Gerrit-Jan
Publicado em 2013

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

Por Saadatmand, Sepideh, Rutgers, Emiel J T, Tollenaar, RobAEM, Zonderland, Hermien M, Ausems, MargreetGEM, Keymeulen, KristienBMI, Schlooz-Vries, Margreet S, Koppert, Linetta B, Heijnsdijk, Eveline A M, Seynaeve, Caroline, Verhoef, Cees, Oosterwijk, Jan C, Obdeijn, Inge-Marie, de Koning, Harry J, Tilanus-Linthorst, Madeleine M A
Publicado em 2012

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuv...

Por Bartlett, John M.S., Brookes, Cassandra L., Robson, Tammy, van de Velde, Cornelis J.H., Billingham, Lucinda J., Campbell, Fiona M., Grant, Margaret, Hasenburg, Annette, Hille, Elysée T.M., Kay, Charlene, Kieback, Dirk G., Putter, Hein, Markopoulos, Christos, Kranenbarg, Elma Meershoek-Klein, Mallon, Elizabeth A., Dirix, Luc, Seynaeve, Caroline, Rea, Daniel
Publicado em 2011